4//SEC Filing
Avoro Capital Advisors LLC 4
Accession 0001209191-23-038675
CIK 0001422142other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 8:59 PM ET
Size
10.2 KB
Accession
0001209191-23-038675
Insider Transaction Report
Form 4
Aghazadeh Behzad
Director10% OwnerOther
Transactions
- Award
Stock Option (right to buy)
2023-06-15+28,255→ 28,255 totalExercise: $8.20Exp: 2033-06-15→ Common Stock (28,255 underlying)
Avoro Capital Advisors LLC
Director10% OwnerOther
Transactions
- Award
Stock Option (right to buy)
2023-06-15+28,255→ 28,255 totalExercise: $8.20Exp: 2033-06-15→ Common Stock (28,255 underlying)
Avoro Ventures LLC
Director10% OwnerOther
Transactions
- Award
Stock Option (right to buy)
2023-06-15+28,255→ 28,255 totalExercise: $8.20Exp: 2033-06-15→ Common Stock (28,255 underlying)
Footnotes (3)
- [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 15, 2023.
- [F2]This Form 4 is filed by Avoro Capital Advisors LLC, a Delaware limited liability company ("Avoro Capital Advisors"), Avoro Ventures LLC, a Delaware limited liability company ("Avoro Ventures") and Behzad Aghazadeh ("Dr. Aghazadeh", and together with Avoro Capital Advisors and Avoro Ventures, the "Reporting Persons"). Dr. Aghazadeh serves as the portfolio manager and controlling person of Avoro Capital Advisors and Avoro Ventures LLC.
- [F3]The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
Documents
Issuer
Aadi Bioscience, Inc.
CIK 0001422142
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001633313
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 8:59 PM ET
- Size
- 10.2 KB